Katarzyna Osetek-Müller, PhD, is a scientist specializing in immunoassays, molecular biology, and genetics.

At Bavarian Nordic in Martinsried near Munich, she leads the development of an ELISA assay to replace animal testing in quality control of the Tick-Borne Encephalitis (TBE) vaccine and evaluates immunoreactivity of the Chikungunya Virus-like Particle (CHIKV VLP) vaccine.

Previously, Katarzyna was Team Lead and Deputy Head of Reproductive Genetics at MVZ Martinsried GmbH (Medicover Genetics), where she managed an international team and advanced molecular diagnostics for reproductive health. Her expertise includes assay development and validation, whole genome amplification, next generation sequencing, and diagnostics for monogenic disorders and infertility.

She earned her PhD in Regenerative Sciences from Hannover Medical School, studying pluripotent stem cell induction and genetic stability, and a Master’s in Biology from Jagiellonian University, focusing on gene mapping in mouse gametes.

Outside the lab, Katarzyna enjoys skiing, dancing, and traveling.